[Gene and cell therapy approaches to cardiovascular and systemic diseases in modelic experiments on animals]
Related Experiment Video
Updated: Jul 25, 2026
07:35
Gene Transfer for Ischemic Heart Failure in a Preclinical Model
Published on: May 15, 2011
Biomeditsinskaia Khimiia
|December 14, 2005
Insights
Gene and cell therapies show promise for treating cardiovascular and systemic diseases. These advanced treatments offer new hope for conditions like myocardial ischemia and postangioplasty restenosis.
Area of Science:
- Cardiovascular medicine
- Regenerative medicine
- Molecular biology
Context:
- Cardiovascular and systemic diseases pose significant health challenges.
- Current treatments for conditions like myocardial ischemia and arteriosclerosis have limitations.
Purpose:
- To explore the therapeutic potential of gene and cell therapy.
- To review applications in cardiovascular and systemic diseases.
Summary:
- Gene and cell therapies are investigated for treating myocardial ischemia, postangioplasty restenosis, hypertension, arteriosclerosis, and trombogenicity.
- Applications also extend to managing posttransplantation complications.
Impact:
- Gene and cell therapy represent a promising frontier in managing complex diseases.
- These advanced therapies could offer novel treatment strategies and improve patient outcomes.
Abstract:
The therapeutic potential of gene and cell therapy in cardiovascular and systemic disease such as myocardial ishemia, postangioplasty restenosis, hypertensia, arteriosclerosis, trombogenicity, posttransplantation complications is considered.
